| LDR | 00945nam a22003131 4500 | ||
| 001 | 001573007 | ||
| 003 | MiAaHDL | ||
| 005 | 20210817000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 891207s1973 stka 00110 eng d | ||
| 010 | ⊔ | ⊔ | ‡a73166463 |
| 015 | ⊔ | ⊔ | ‡aGB73-05731 |
| 020 | ⊔ | ⊔ | ‡a0443010021: ‡c£1.25 |
| 035 | ⊔ | ⊔ | ‡a(MiU)990015730070106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990015730070106381 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)2722640 |
| 035 | ⊔ | ⊔ | ‡a(SAZTEC)126201000 |
| 035 | ⊔ | ⊔ | ‡a(CaOTULAS)175800780 |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph001573007 |
| 040 | ⊔ | ⊔ | ‡aLC |
| 050 | ⊔ | 0 | ‡aRM300 ‡b.T86 |
| 082 | ⊔ | ⊔ | ‡a615/.1 |
| 100 | 1 | ⊔ | ‡aTurner, Paul. |
| 245 | 1 | 0 | ‡aClinical pharmacology ‡c[by] Paul Turner, Alan Richens. - |
| 260 | ⊔ | ⊔ | ‡aEdinburgh: ‡bChurchill Livingstone, ‡c1973. |
| 300 | ⊔ | ⊔ | ‡avii, 246 p.: ‡billus.; ‡c19 cm. - |
| 490 | 0 | ⊔ | ‡aLivingstone medical text |
| 500 | ⊔ | ⊔ | ‡aIncludes index. |
| 500 | ⊔ | ⊔ | ‡aImprint covered by label: Williams & Wilkins Co., Baltimore. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aPharmacology |
| 650 | ⊔ | 0 | ‡aChemotherapy |
| 700 | 1 | ⊔ | ‡aRichens, Alan, ‡ejoint author. |
| CID | ⊔ | ⊔ | ‡a001573007 |
| DAT | 0 | ⊔ | ‡a19891207000000.0 ‡b20210817000000.0 |
| DAT | 1 | ⊔ | ‡a20210922183820.0 ‡b2023-06-24T18:12:08Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990015730070106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015072266995 ‡sMIU ‡1990015730070106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cMIU ‡d20230624 ‡sgoogle ‡umdp.39015072266995 ‡y1973 ‡ric ‡qbib ‡tnon-US bib date1 >= 1929 |